Ardelyx reported $114.22M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbott ABT:US $ 23429M 810M
Amgen AMGN:US $ 18520M 865M
Ardelyx ARDX:US $ 114.22M 19.42M
Astrazeneca AZN:US 22.65B 3.6B
Biocept BIOC:US $ 47.58M 1.89M
Chimerix CMRX:US 62.55M 33.25M
Corcept Therapeutics CORT:US $ 388.22M 121.76M
Curis CRIS:US $ 126.14M 3.76M
Life Technologies LIFE:US $ 103.12M 10.45M
Opko Health OPK:US $ 754.07M 68.94M
Tg Therapeutics TGTX:US $ 242.22M 88.75M
United Therapeutics UTHR:US $ 2586.6M 263M
Xoma XOMA:US $ 89.61M 7.36M